Hislop, JQuayyum, ZElders, AFraser, CJenkinson, DMowatt, GSharma, PVale, LPetty, R2011-09-132011-09-132011Hislop, J, Quayyum, Z, Elders, A, Fraser, C, Jenkinson, D, Mowatt, G, Sharma, P, Vale, L & Petty, R 2011, 'Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day : a systematic review and economic evaluation', Health Technology Assessment, vol. 15, no. 25, pp. 1-178. https://doi.org/10.3310/hta152502046-4924http://hdl.handle.net/2164/21231781615273engR MedicineChief Scientist Office (CSO)CSO--HERU2CSO--HSRU1RJournal article10.3310/hta152501525